መነሻ › አሠሪዎች › Akston Biosciences Corporation
Akston Biosciences Corporation: H-1B ደመወዞች እና ስፖንሰርሺፕ
Akston Biosciences Corporation በፋይናንስ ዓመታት 2023–2026 ለH-1B እና ለተዛማጅ ቪዛዎች 17 የሥራ ሁኔታ ማመልከቻዎችን አቅርቧል፤ የተረጋገጡ፡ 17። መካከለኛ የተገለጸ ደመወዝ፡ $76,500።
Akston Biosciences Corporation H-1B ቪዛዎችን ይደግፋል?
Akston Biosciences Corporation በፋይናንስ ዓመታት 2023–2026 17 የሥራ ሁኔታ ማመልከቻዎችን አቅርቧል፤ የቅርብ ጊዜ የቀረበው በ28 ሜይ 2026። LCA የH-1B ጥያቄ የመጀመሪያ ደረጃ ስለሆነ፣ አሠሳሪው H-1B ሠራተኞችን ደግፏል ወይም ለመደገፍ ተዘጋጅቷል፤ ለማንኛውም የተወሰነ ሥራ ስፖንሰርሺፕ አያረጋግጥም። የአሠሳሪውን የራሱ የሥራ ዝርዝሮች ይመልከቱ።
በሥራ ማዕረግ የተከፋፈሉ ደመወዞች
| የስራ አስፈጻሚ | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| Quality Control Associate I | 3 | $58,000 |
| Quality Assurance Associate II | 1 | $77,000 |
| Manager, Upstream Product Development | 1 | $132,000 |
| Quality Control Manager | 1 | $137,030 |
| Quality Control Associate II | 1 | $75,000 |
| Business Development Associate | 1 | $105,000 |
| Engineer II, Manufacturing Compliance | 1 | — |
| Quality Control Associate III | 1 | $75,000 |
| Quality Assurance Associate | 1 | $76,000 |
| Engineer I, Process Development | 1 | $87,200 |
| Quality Assurance Specialist | 1 | — |
| Associate I, Quality Control (Materials) | 1 | $70,000 |
| Research Associate (Pharmacology) | 1 | $70,000 |
| Compliance Engineer II (Manufacturing) | 1 | $90,000 |
| Associate II, Quality Assurance | 1 | $85,000 |
በፋይናንስ ዓመት መሠረት ማመልከቻዎች
| የፋይናንስ ዓመት | LCAs | መካከለኛ ደመወዝ |
|---|---|---|
| FY2023 | 2 | $104,500 |
| FY2024 | 6 | $75,000 |
| FY2025 | 4 | $76,000 |
| FY2026 | 5 | $77,500 |
የሚገባ ደመወዝ ደረጃዎች
የሥራ ሚኒስቴር ለእያንዳንዱ ሙያ እና አካባቢ ከደረጃ I (መግቢያ) እስከ ደረጃ IV (ሙሉ በሙሉ ብቁ) ድረስ አራት የሚገባ ደመወዝ ደረጃዎችን ይወስናል። አሠሳሪው ከሥራው መስፈርቶች ጋር የሚስማማውን ደረጃ ይመርጣል።
ሥራዎቹ የት እንዳሉ
ሙያዎች
- Biological Technicians6
- Regulatory Affairs Specialists4
- Industrial Engineers3
- Molecular and Cellular Biologists1
- Chemists1
- Marketing Managers1
- Chemical Engineers1
የቅርብ ጊዜ ማመልከቻዎች
| የስራ አስፈጻሚ | መሠረታዊ ደመወዝ | አድራሻ | የቀረበበት | የመጀመሪያ ቀን | ሁኔታ |
|---|---|---|---|---|---|
| Associate I, Quality Control (Materials) | $70,000–$90,000 ደረጃ III | Beverly, MA | 28 ሜይ 2026 | 1 ኦክቶ 2026 | የተረጋገጠ |
| Compliance Engineer II (Manufacturing) | $90,000–$100,000 ደረጃ I | Beverly, MA | 28 ሜይ 2026 | 1 ኦክቶ 2026 | የተረጋገጠ |
| Research Associate (Pharmacology) | $70,000–$90,000 ደረጃ III | Beverly, MA | 28 ሜይ 2026 | 1 ኦክቶ 2026 | የተረጋገጠ |
| Associate II, Quality Assurance | $85,000–$100,000 ደረጃ II | Beverly, MA | 28 ሜይ 2026 | 1 ኦክቶ 2026 | የተረጋገጠ |
| Quality Assurance Specialist | $83,200–$124,800 ጊዜያዊ · ደረጃ II | Beverly, MA | 3 ዲሴም 2025 | 15 ዲሴም 2025 | የተረጋገጠ |
| Quality Assurance Associate | $76,000–$90,000 ደረጃ II | Beverly, MA | 30 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ |
| Engineer I, Process Development | $87,200–$100,000 ደረጃ I | Beverly, MA | 30 ሜይ 2025 | 1 ኦክቶ 2025 | የተረጋገጠ |
| Engineer II, Manufacturing Compliance | $83,200–$104,000 ጊዜያዊ · ደረጃ I | Beverly, MA | 6 ዲሴም 2024 | 25 ጃንዩ 2025 | የተረጋገጠ |
| Quality Control Associate III | $75,000–$100,000 ደረጃ III | Beverly, MA | 25 ሴፕቴ 2024 | 7 ማርች 2025 | የተረጋገጠ |
| Quality Control Associate I | $62,400–$104,000 ጊዜያዊ · ደረጃ II | Beverly, MA | 18 ሴፕቴ 2024 | 18 ሴፕቴ 2024 | የተረጋገጠ |
| Quality Control Associate I | $58,000–$80,000 ደረጃ II | Beverly, MA | 5 ሴፕቴ 2024 | 16 ሴፕቴ 2024 | የተረጋገጠ |
| Quality Control Associate I | $58,000–$80,000 ደረጃ II | Beverly, MA | 21 ኦገስ 2024 | 1 ሴፕቴ 2024 | የተረጋገጠ |
| Quality Control Associate II | $75,000–$100,000 ደረጃ II | Beverly, MA | 24 ሜይ 2024 | 1 ኦክቶ 2024 | የተረጋገጠ |
| Business Development Associate | $105,000–$125,000 ደረጃ I | Beverly, MA | 23 ሜይ 2024 | 1 ኦክቶ 2024 | የተረጋገጠ |
| Quality Control Manager | $137,030–$145,000 ደረጃ IV | Beverly, MA | 28 ዲሴም 2023 | 26 ኤፕሪ 2024 | የተረጋገጠ |
| Manager, Upstream Product Development | $132,000–$160,000 ደረጃ IV | Beverly, MA | 5 ሴፕቴ 2023 | 11 ኖቬም 2023 | የተረጋገጠ |
| Quality Assurance Associate II | $77,000–$90,000 ደረጃ I | Beverly, MA | 31 ማርች 2023 | 1 ሜይ 2023 | የተረጋገጠ |
ደመወዞች በእያንዳንዱ ማመልከቻ ላይ በተገለጸው ደመወዝ ዝቅተኛ ጫፍ ሲሆኑ ወደ ዓመታዊ መጠን ተቀይረዋል፤ ስታቲስቲክሶች የተረጋገጡ ሙሉ ጊዜ ማመልከቻዎችን ብቻ ይጠቀማሉ። LCA የቪዛ ማረጋገጫ አይደለም፤ አንድ LCA ለብዙ ቦታዎች ሊሸፍን ይችላል። ምንጭ፡ የአሜሪካ የሥራ ሚኒስቴር፣ OFLC LCA መረጃ ማሳያ መረጃ፣ የፋይናንስ ዓመታት 2023–2026 (የቅርብ ጊዜ ውሳኔ 30 ጁን 2026)።